Venous thrombosis: Factor V G1691A genotyping related to APC resistance as measured by 2 methods

European Journal of Haematology

Volumn 58, Issue 4, 1997, Pages 229-232

  Alderborn, Anders ^a   Siegbahn, Agneta ^a   Wadelius, Claes ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APC resistance; deep venous thrombosis; factor V

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030907104     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb01659.x     Document Type: Article

References (12)

1. DAHLBÄCK B, CARLSSON M, SVENSSON PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. PNAS 1993: 90: 1004-1008.
2. KOSTER T, ROSENDAAL FR, DE RONDE H, BRIET E, VANDENBROUCKE JP, BERTINA RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993: 342: 1503-1506.
3. BERTINA RM, KOELEMAN BPC, KOSTER T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369: 64-67.
4. ZÖLLER B, DAHLBÄCK B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994: 343: 1536-1538.
5. VANDENBROUCKE JP, KOSTER T, BRIET E, REITSMA PH, BERTINA RM, ROSENDAAL FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994: 344: 1453-1457.
6. SAMBROOK J, FRITSCH EF, MANIATIS T. Molecular cloning, a laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory, 1989.
7. JORQUERA JI, MONTORO JM, FERNÁNDEZ MA, AZNAR JA, AZNAR J. Modified test for activated protein C resistance. Lancet 1994: 344: 1162-1163.
8. ZÖLLER B, SVENSSON PJ, HE X, DAHLBÄCK B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994: 94: 2521-2524.
9. BERTINA RM, REITSMA PH, ROSENDAAL FR, VANDENBROUCKE JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995: 74: 449-453.
10. REES DC, COX M, CLEGG JB. World distribution of factor V Leiden. Lancet 1995: 346: 1133-1134.
11. KOELEMAN BPC, REITSMA PH, ALLAART CF, BERTINA RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994: 84: 1031-1035.
12. ZÖLLER B, BERNTSDOTTER A, GARCIA DE FRUTOS P, DAHLBÄCK B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995: 85: 3518-3523.